De novo B-cell prolymphocytic leukemia with central nervous system involvement

References

• Dearden C. How I treat prolymphocytic leukemia. Blood 2012; 120:538–551.
   PubMed Web of Science ®Google Scholar
• Polizzotto MN, Tam CS, Milner A, et al. The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders. Cancer 2006;107:773–780.
   PubMed Web of Science ®Google Scholar
• Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 2008;19:379–390.
   PubMed Web of Science ®Google Scholar
• Galton DA, Goldman JM, Wiltshaw E, et al. Prolymphocytic leukaemia. Br J Haematol 1974;27:7–23.
   PubMed Web of Science ®Google Scholar
• Melo JV, Catovsky D, Galton DA. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.Br J Haematol 1986;63:377–387.
   PubMed Web of Science ®Google Scholar
• Freedman AS, Aster JC, Dearden C. Clinical manifestations, pathologic features, and diagnosis of B cell prolymphocytic leukemia. In: Lister A, editor. UpToDate. Waltam, MA: UpToDate; 2012. Available from: www.uptodate.com
   Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization classification of tumours of haemotopoietic and lymphoid tissues. Lyon: IARC Press; 2008. pp 183–184.
   Google Scholar
• Nayak KS, Shankarnarayanan, Naik R, et al. Prolymphocytic leukaemia–report of three cases. J Indian Med Assoc 2004;102: 379–380.
   PubMedGoogle Scholar
• Hoffman MA, Valderrama E, Fuchs A, et al. Leukemic meningitis in B-cell prolymphocytic leukemia. A clinical, pathologic, and ultrastructural case study and a review of the literature. Cancer 1995;75: 1100–1103.
   PubMed Web of Science ®Google Scholar
• Morrison C, Shah S, Flinn IW. Leptomeningeal involvement in chronic lymphocytic leukemia. Cancer Pract 1998;6:223–228.
   PubMedGoogle Scholar
• Hanse MC, Van't Veer MB, van Lom K, et al. Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment. J Neurol 2008;255:828–830.
   PubMed Web of Science ®Google Scholar
• Benjamini O, Jain P, Schlette E, et al. Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease?Clin Lymphoma Myeloma Leuk 2013;13:338–341.
   PubMed Web of Science ®Google Scholar
• Kernoff LM, Coghlan PJ. Prolymphocytic leukaemia with leukaemic meningitis and extralymphoid tumours. A case report. S Afr Med J 1983;64:290–292.
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Richards SM, Chopra R, et al. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood 2006;108:465–472.
   PubMed Web of Science ®Google Scholar
• Chang H, Brandwein J, Yi QL, et al. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res 2004;28:1007–1011.
   PubMed Web of Science ®Google Scholar
• Moazzam AA, Drappatz J, Kim RY, et al. Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review. J Neurooncol 2012;106:185–200.
   PubMed Web of Science ®Google Scholar
• West RJ, Graham-Pole J, Hardisty RM, et al. Factors in pathogenesis of central-nervous-system leukaemia. Br Med J 1972;3:311–314.
   PubMed Web of Science ®Google Scholar
• Sheaff MT, van der Walt JD, Geddes JF, et al. Prolymphocytic transformation of chronic lymphocytic leukaemia manifesting as a cerebellar lymphoma. Br J Neurosurg 1994;8:735–738.
   PubMed Web of Science ®Google Scholar
• Ravandi F, Cortes J, Estrov Z, et al. CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res 2002;26:643–649.
   PubMed Web of Science ®Google Scholar
• Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988;68:835–853.
   PubMed Web of Science ®Google Scholar
• Menet A, Speth C, Larcher C, et al. Epstein-Barr virus infection of human astrocyte cell lines. J Virol 1999;73:7722–7733.
   PubMed Web of Science ®Google Scholar
• Gobbi M, Tazzari PL, Raspadori D, et al. Meningeal leukemia complicating prolymphocytoid transformation of B-chronic lymphocytic leukemia. Acta Haematol 1985;74:205–207.
   PubMed Web of Science ®Google Scholar
• Wang ML, Shih LY, Dunn P, et al. Meningeal involvement in B-cell chronic lymphocytic leukemia: report of two cases. J Formos Med Assoc 2000;99:775–778.
   PubMed Web of Science ®Google Scholar
• Kuwabara H, Kanamori H, Takasaki H, et al. Involvement of central nervous system in prolymphocytoid transformation of chronic lymphocytic leukemia. Leuk Lymphoma 2003;44:1235–1237.
   PubMed Web of Science ®Google Scholar
• Thiruvengadam R, Bernstein ZP. Central nervous system involvement in prolymphocytic transformation of chronic lymphocytic leukemia. Acta Haematol 1992;87:163–164.
   PubMed Web of Science ®Google Scholar
• Singh AK, Thompson RP. Leukaemic meningitis in chronic lymphocytic leukaemia. Acta Haematol 1986;75:113–115.
   PubMed Web of Science ®Google Scholar
• Pamuk GE, Puyan FO, Unlu E, et al. The first case of de novo B-cell prolymphocytic leukemia with central nervous system involvement: description of an unreported complication. Leuk Res 2009; 33:864–867.
   PubMed Web of Science ®Google Scholar
• Lopez Guillermo A, Cervantes F, Blade J, et al. Central nervous system involvement demonstrated by immunological study in prolymphocytic variant of chronic lymphocytic leukemia. Acta Haematol 1989;81:109–111.
   PubMed Web of Science ®Google Scholar